Polypeptides with xylanase activity
View Patent ↗Polypeptides with xylanase activity modified to increase bran solubilization and/or xylanase activity. The modification comprises modification of one or more amino acids in position 12 or 13 in combination with one or more further amino acid modifications in position 15, 34, 54, 77, 81, 82, 99, 104, 110, 113, 114, 118, 122, 141, 154, 159, 162, 164, 166, 175 or 179, wherein the positions are determined as the position corresponding the position of Bacillus subtilis xylanase (SEQ ID NO 1).
1. An isolated polypeptide having xylanase activity and comprising an amino acid sequence, said amino acid sequence having at least 85% identity with the amino acid sequence set forth in SEQ ID NO: 1, and which polypeptide has
i) one or two amino acid substitutions in a position selected from the group consisting of: 12 and 13; and
ii) one or more further amino acid substitutions in a position selected from the group consisting of: 15, 34, 54, 77, 81, 82, 99, 104, 110, 113, 114, 118, 122, 141, 154, 159, 162, 164, 166, 175, and 179,
wherein said positions are determined as the position corresponding to the position of B. subtilis xylanase sequence shown as SEQ ID NO: 1 by alignment;
wherein the amino acid modification in position 12 is an amino acid substitution to any one different amino acid residue selected from the group consisting of: isoleucine, alanine, leucine, asparagine, lysine, aspartic acid, methionine, cysteine, glutamic acid, threonine, glutamine, tryptophan, valine, proline, serine, tyrosine, arginine, and histidine; and
wherein the amino acid substitution in position 13 is an amino acid substitution to any one different amino acid residue selected from the group consisting of: alanine, leucine, asparagine, lysine, aspartic acid, methionine, cysteine, glutamic acid, threonine, glutamine, tryptophan, valine, proline, serine, tyrosine, arginine, and histidine.
2. The isolated polypeptide according to claim 1 , comprising one or more amino acid substitutions selected from the group consisting of: 13Y, 15Y, 34K, 77V, 77M, 77Y, 77L, 77S, 81I, 82I, 99Y, 104W, 110A, 113D, 113A, 114F, 114D, 114Y, 118V, 122F, 122D, 154R, 159D, 162E, 162D, 164F, 166F, 175L, 175K, 175E, 175Y, and 179Y, the position(s) being determined as the corresponding position of B. subtilis amino acid sequence shown as SEQ ID NO: 1.
3. The isolated polypeptide according to claim 1 , wherein said polypeptide has at least 90% identity to SEQ ID NO: 1.
4. The isolated polypeptide according to claim 1 , having a β-jelly roll fold.
5. The isolated polypeptide according to claim 1 , wherein the amino acid modification in position 12 is a substitution to a tyrosine.
6. The isolated polypeptide according to claim 1 , wherein the amino acid modification in position 13 is a substitution to a tyrosine.
7. The isolated polypeptide according to claim 1 having a total number of amino acids of less than 250 amino acids.
8. The polypeptide according to claim 1 , comprising one or more amino acid substitutions selected from the group consisting of: 13Y, 110A, 122D, 113A, 13Y, 113D, 175L, 122F, 34K, 99Y, 104W, 154R, 159D, 175K, 81I, 166F, 162E, 162D, 164F, 114D, 114Y, 114F, 118V, 175K, 77L, 77M, 77S, 77V, and 77Y, the position(s) being determined as the corresponding position of B. subtilis amino acid sequence shown as SEQ ID NO: 1.
9. A composition comprising the isolated polypeptide according to claim 1 admixed with a non toxic component.
10. A method of preparing an isolated polypeptide according to claim 1 , said method comprising expressing a nucleotide sequence encoding said polypeptide; and optionally isolating and/or purifying the polypeptide after expression.